Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Avidity Biosciences, Inc. (RNA)  
$29.51 0.27 (0.92%) as of 4:30 Tue 5/21


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 79,511,000
Market Cap: 2.35(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.87 - $29.51
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avidity Biosciences is a biopharmaceutical company developing a new class of RNA therapies called Antibody Oligonucleotide Conjugates (AOCs) designed to combine the specificity of monoclonal antibodies, or mAbs, with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. Co.'s lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare monogenic muscle disease. Co. pipeline also includes AOC 1044, the lead of three programs for the treatment of Duchenne Muscular Dystrophy, and AOC 1020, designed to treat facioscapulohumeral muscular dystrophy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 424,641 439,402 439,402 679,502
Total Sell Value $10,058,674 $10,208,203 $10,208,203 $15,676,820
Total People Sold 3 5 5 5
Total Sell Transactions 11 16 16 29
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 89
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Levin Arthur A Director   –       •      –    2024-05-20 4 AS $29.90 $149,481 D/D (5,000) 14,830     -
   Levin Arthur A Director   –       •      –    2024-05-20 4 OE $1.24 $6,200 D/D 5,000 19,830     -
   Maclean Michael F Chief Financial Officer   •       –      –    2024-05-14 4 AS $28.28 $2,121,045 D/D (75,000) 44,093 2%     
   Maclean Michael F Chief Financial Officer   •       –      –    2024-05-14 4 OE $8.82 $661,500 D/D 75,000 119,093     -
   Boyce Sarah President and CEO   •       •      –    2024-05-07 4 AS $25.54 $715,050 D/D (28,000) 112,117 16%     
   Boyce Sarah President and CEO   •       •      –    2024-05-07 4 OE $1.24 $34,720 D/D 28,000 140,117     -
   Levin Arthur A Director   –       •      –    2024-04-19 4 AS $22.82 $114,123 D/D (5,000) 14,830 30%     
   Levin Arthur A Director   –       •      –    2024-04-19 4 OE $1.24 $6,200 D/D 5,000 19,830     -
   Levin Arthur A Director   –       •      –    2024-04-03 4 S $27.11 $542,214 I/I (20,000) 253,872 -11%     
   Boyce Sarah President and CEO   •       •      –    2024-04-02 4 S $26.25 $734,919 D/D (28,000) 112,117 -10%     
   Boyce Sarah President and CEO   •       •      –    2024-04-02 4 OE $1.24 $34,720 D/D 28,000 140,117     -
   Levin Arthur A Director   –       •      –    2024-03-19 4 S $23.97 $119,848 D/D (5,000) 14,830 -24%     
   Levin Arthur A Director   –       •      –    2024-03-19 4 OE $1.24 $6,200 D/D 5,000 19,830     -
   Maclean Michael F Chief Financial Officer   •       –      –    2024-03-13 4 S $24.52 $980,760 D/D (40,000) 44,093 -19%     
   Maclean Michael F Chief Financial Officer   •       –      –    2024-03-13 4 OE $8.82 $352,800 D/D 40,000 84,093     -
   Levin Arthur A Director   –       •      –    2024-03-12 4 S $22.00 $609,017 D/D (27,641) 14,830 -30%     
   Levin Arthur A Director   –       •      –    2024-03-12 4 OE $1.24 $31,000 D/D 25,000 42,471     -
   Boyce Sarah President and CEO   •       •      –    2024-03-12 4 S $22.63 $633,682 D/D (28,000) 112,117 -30%     
   Boyce Sarah President and CEO   •       •      –    2024-03-12 4 OE $1.24 $34,720 D/D 28,000 140,117     -
   Boyce Sarah President and CEO   •       •      –    2024-03-08 4 S $21.39 $1,796,710 D/D (84,000) 112,117 -38%     
   Boyce Sarah President and CEO   •       •      –    2024-03-08 4 OE $1.24 $104,160 D/D 84,000 196,117     -
   Boyce Sarah President and CEO   •       •      –    2024-03-01 4 S $20.13 $1,691,306 D/D (84,000) 112,117 -47%     
   Boyce Sarah President and CEO   •       •      –    2024-03-01 4 OE $1.24 $104,160 D/D 84,000 196,117     -
   Levin Arthur A Director   –       •      –    2024-01-22 4 AS $10.13 $18,832 D/D (1,859) 17,471 184%     
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2024-01-22 4 AS $10.13 $20,918 D/D (2,065) 17,035 184%     
  89 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us